DEVELOPMENT OF A NEW QUESTIONNAIRE FOR IDENTIFING PREDICTIVE FACTORS INFLUENCING WEIGHT LOSS THERAPIES

Author(s)

Miguel Angel Ruíz, PhD, Psychologist1, Miguel Costa, PhD, Psychologist1, Miguel Angel Rubio, MD, Endocrinologist2, Itziar Iruarrizaga, PhD, Psychologist3, Carlos Almendro, MD, General Practitioner4, Basilio Moreno, MD, Endocrinologist5, Javier Salvador, MD, Endocrinologist6, Juan Antón, MD, General Practitioner7, Concepción Bande, Bsc, Nurse8, Maria Soledad García Pulgar, B, Pharm, Pharmacoeconomic Specialist91Universidad Autónoma de Madrid, Madrid, Spain; 2 Hospital Clínico Universitario San Carlos, Madrid, Spain; 3 Universidad Complutense de Madrid, Madrid, Spain; 4 Centro de Salud Torrent, Valencia, Spain; 5 Hospital General Universitario Gregorio Marañón, Madrid, Spain; 6 Clínica Universitaria de Navarra, Pamplona/Iruña, Spain; 7 CAP Manso, Barcelona, Spain; 8 Complejo Hospitalario Cristal-Piñor, Orense, Spain; 9 Roche Farma S.A, Madrid, Spain

OBJECTIVES: To develop a multidimensional specific questionnaire of factors related to weight loss therapies proposed for the assessment of therapy success or failure. METHODS: Three focus groups of patients where debriefed and an expert panel gathered relevant issues and converted them into 54 items around 9 dimensions: Alimentary Habits, Expectations towards Therapy, Effort and Concern, Emotion, Confidence, Believes, Motivation towards Physical Exercise, Motivation towards Weight Loss, and Perceived Control. Comprehension and legibility were questioned in a pilot sample. A first item reduction was done to avoid redundancies and to establish content agreement. Item reduction was carried out in a sample of patients using factor analysis. Feasibility, reliability, content validity and factor validity were assessed. RESULTS: A panel of 11 practitioners and researchers, belonging to different health centers in the Community of Madrid gathered 3 samples: One sample of 8 chronic patients participating in 3 focus groups; a sample of 8 patients to assess feasibility; a sample of 121 patients for item reduction. A first conceptual reduction conveyed a 32 item version. After measurement in a representative sample a final 17 items form was accepted. Items were arranged around 6 dimensions: Impulsiveness, External Locus of Control, Internal Locus of Control, Emotiveness, Motivation towards Therapy and Exercise, and Personal Image. Overall Cronbach's a was 0.772 (ICC 95% confidence interval = 0.698-0.835). The 6 dimensions solution accounted for 71.2% of variance, with all eigenvalues above 1. CONCLUSIONS: The new questionnaire is a very short inventory of factors which might have screening properties in order to forecast the efficacy of weight loss therapies. Although further prospective research is being carried out in order to assess predictive validity, basic psychometric properties are good as a baseline model. Resulting dimensions are meaningful and well formed.

Conference/Value in Health Info

2006-10, ISPOR Europe 2006, Copenhagen, Denmark

Value in Health, Vol. 9, No.6 (November/December 2006)

Code

POB9

Topic

Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes

Disease

Diabetes/Endocrine/Metabolic Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×